Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma
Authors
Keywords
USP39, Melanoma, Cell cycle arrest, Apoptosis, ERK
Journal
TUMOR BIOLOGY
Volume 37, Issue 10, Pages 13167-13176
Publisher
Springer Nature
Online
2016-07-25
DOI
10.1007/s13277-016-5212-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Metabolic control of methylation and acetylation
- (2016) Xiaoyang Su et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Advances in targeted therapy for unresectable melanoma: New drugs and combinations
- (2015) Mengze Hao et al. CANCER LETTERS
- Reduced USP39 expression inhibits malignant proliferation of medullary thyroid carcinoma in vitro
- (2015) Yong An et al. World Journal of Surgical Oncology
- The MAPK pathway across different malignancies: A new perspective
- (2014) Mauricio Burotto et al. CANCER
- RETRACTED ARTICLE: Targeted immune therapy of ovarian cancer
- (2014) Keith L. Knutson et al. CANCER AND METASTASIS REVIEWS
- Oncogenes in melanoma: An update
- (2014) Manfred Kunz EUROPEAN JOURNAL OF CELL BIOLOGY
- Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance
- (2014) Anna Wojtuszkiewicz et al. Expert Opinion on Drug Metabolism & Toxicology
- An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth
- (2014) A. S. Adler et al. GENES & DEVELOPMENT
- Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
- (2014) Grant A McArthur et al. LANCET ONCOLOGY
- Emerging Functions of SRSF1, Splicing Factor and Oncoprotein, in RNA Metabolism and Cancer
- (2014) S. Das et al. MOLECULAR CANCER RESEARCH
- Targeting RAS–ERK signalling in cancer: promises and challenges
- (2014) Ahmed A. Samatar et al. NATURE REVIEWS DRUG DISCOVERY
- The crystal structure of S. cerevisiae Sad1, a catalytically inactive deubiquitinase that is broadly required for pre-mRNA splicing
- (2014) H. Hadjivassiliou et al. RNA
- Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy
- (2013) V. Quidville et al. CANCER RESEARCH
- BRAF in Melanoma: Current Strategies and Future Directions
- (2013) A. K. S. Salama et al. CLINICAL CANCER RESEARCH
- Cutaneous melanoma
- (2013) Alexander MM Eggermont et al. LANCET
- Tumor adaptation and resistance to RAF inhibitors
- (2013) Piro Lito et al. NATURE MEDICINE
- Overexpression of TROP2 Predicts Poor Prognosis of Patients with Cervical Cancer and Promotes the Proliferation and Invasion of Cervical Cancer Cells by Regulating ERK Signaling Pathway
- (2013) Ting Liu et al. PLoS One
- Functional roles of protein splicing factors
- (2012) Hsin‑Chou Chen et al. BIOSCIENCE REPORTS
- The spliceosome as a target of novel antitumour drugs
- (2012) Sophie Bonnal et al. NATURE REVIEWS DRUG DISCOVERY
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness
- (2011) D. Rossi et al. BLOOD
- Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of Aurora B
- (2011) Renske J. van Leuken et al. CELL CYCLE
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
- (2011) Timothy A Graubert et al. NATURE GENETICS
- SF3B1and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
- (2011) Lili Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deubiquitinases in cancer: new functions and therapeutic options
- (2011) J M Fraile et al. ONCOGENE
- Zebrafish usp39 Mutation Leads to rb1 mRNA Splicing Defect and Pituitary Lineage Expansion
- (2011) Yesenia Ríos et al. PLoS Genetics
- CDK Inhibitors: Cell Cycle Regulators and Beyond
- (2008) Arnaud Besson et al. DEVELOPMENTAL CELL
- Aberrant RNA splicing and its functional consequences in cancer cells
- (2008) J. D. Fackenthal et al. Disease Models & Mechanisms
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now